Global Throat Lozenges Market Comprehensive Study: Forecasted Market Size And Growth Rate | GlaxoSmithKline plc, SSL International plc, Thornton & Ross, Pfizer Inc., The Procter & Gamble Company, Bausch Health Companies Inc., Wrigley Company, Reckitt Benc

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2738

The Business Research Company offers in-depth market insights through Throat Lozenges Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The throat lozenges market size has grown strongly in recent years. It will grow from $4.89 billion in 2023 to $5.16 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increased incidence of throat discomfort, consumer awareness and self-care trends, preference for natural and herbal ingredients, change in lifestyles and environmental factors, marketing and branding strategies..

The throat lozenges market size is expected to see strong growth in the next few years. It will grow to $6.45 billion in 2028 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to continued prevalence of respiratory conditions, innovation in flavor profiles, e-commerce and online retail growth, health and wellness trends, global respiratory health awareness.. Major trends in the forecast period include e-commerce growth, targeted marketing for specialty formulations, global health events impact, inclusion of soothing herbs and extracts, customization and personalization..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=10824&type=smp

Market Segmentation:
The throat lozenges market covered in this report is segmented -

1) By Type: Hard Candy Lozenges, Soft Lozenges, Compressed Lozenges
2) By Ingredient: Menthol, Mint, Eucalyptus Oil, Peppermint Oil, Honey And Ginger, Lemon, Other Ingredients
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
4) By Application: Sore Throat, Cough And Cold, Throat Diseases

Major Driver - Surging Prevalence Of Respiratory Diseases Drives Growth In The Throat Lozenges Market
The increasing prevalence of respiratory diseases is expected to propel the throat lozenges market going forward. Respiratory diseases refer to a type of disease that affects the lungs and other parts of the respiratory system. Throat lozenges are used to treat respiratory tract infections and diseases. For instance, in September 2022, according to the Forum of International Respiratory Societies (FIRS), a US-based respiratory health advocacy organization, in 2022, globally around 200 million people are affected with chronic obstructive pulmonary disease, or COPD, accounting for roughly 3.2 million deaths annually. Therefore, the increasing prevalence of respiratory diseases will drive the throat lozenges market.

Competitive Landscape:
Major companies operating in the throat lozenges market report are GlaxoSmithKline plc, SSL International plc, Thornton & Ross, Pfizer Inc., The Procter & Gamble Company, Bausch Health Companies Inc., Wrigley Company, Reckitt Benckiser Group plc, Gepach International, Bliss GVS Pharma Ltd, Sanofi S.A, Ricola AG, Honibe, Ernest Jackson & Co Ltd, Doetsch Grether AG, Mondelez International group, Cloetta AB, Golden Throat, Fisherman's Friend, Prestige Brands Inc, HALLS, Dabur India Limited, Churub, Strepsils, Hydrocortisone, Lidocaine, Benzocaine, Phenol, Menthol, Eucalyptus, Cepac, Chlorhexidine, Alcohol, Sucrose, Sorbitol, Mannitol,

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/throat-lozenges-global-market-report

Top Trend - Throat Lozenges Market Advances With Innovative Products
Innovative product offerings are a key trend gaining popularity in the throat lozenges market. Major companies in the throat lozenges market are launching various new and innovative products to sustain their position in the market. For instance, in July 2022, Taiho Pharmaceutical Co Ltd., a Japan-based pharmaceutical company, launched PITAS throat troche. It is a series of film-type lozenges designed to relieve throat pain, swelling, and discomfort. They stick to the roof of the mouth, allowing for discreet use and effectiveness while talking. PITAS Medical Troche is a designated quasi-drug specifically formulated for mouth and throat disinfection.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Throat Lozenges Market Characteristics
3. Throat Lozenges Market Trends And Strategies
4. Throat Lozenges Market - Macro Economic Scenario
5. Throat Lozenges Market Size And Growth
…..
27. Throat Lozenges Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.